>
Organization
Bristol-Myers Squibb Company
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Bristol-Myers Squibb Company

... its Drugs, Services and Continuous Drugs Developments are: AbbVie Merck Gilead Sciences Bristol-Myers Squibb Janssen (Johnson&Johnson) GlaxoSmithKline (GSK) Top 22 Human Immunodeficiency Virus (HIV) Drugs ...
... today provided an update on its proposed acquisition of Celgene Corporation (NASDAQ:CELG). Bristol-Myers Squibb announced that it has filed an amended registration statement on Form ...
... such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, ...
... It was only a month after Bristol-Myers Squibb kicked off 2019 by announcing it would buy Celgene for $74 ...
... in the market.For instance, in March 2017, Foundation Medicine collaborated with Bristol-Myers Squibb Company. This enabled Bristol-Myers Squibb to deploy Foundation Medicine's molecular information solutions ...
... taking part in a free, three-day workshop series funded in part by Bristol-Myers Squibb and led by Acera: the Massachusetts School of Science, Creativity, and ...
... PRINCETON - Bristol-Myers Squibb Company (NYSE: BMY) today announced data evaluating Opdivo (nivolumab) in combination with Yervoy ...
... in prostate cancer—or its PARP inhibitor, for that matter. In 2017, archrival Bristol-Myers Squibb teamed up with PARP drugmaker Clovis Oncology for a phase two ...
... subsidiary of Akebia Therapeutics), Thermo Fisher Scientific, Merck KGaA, Merck & Co., Bristol-Myers Squibb, Cambridge Assessment English, Novartis, Incyte, Sanofi Pasteur, and Red Hat. “This ...
... way in order to attack tumors. The multi-center combination clinical trial by Bristol-Myers Squibb, maker of both drugs, was organized after research published in Nature ...
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/News/bristol-myers-squibb-company-o1345
  • https://relationshipscience.com/News/bristol-myers-squibb-company-o1345
Subscribe now for full coverage on Bristol-Myers Squibb Company
Start My Free Trial